Elena Miranda

1.7k citations
31 papers · 1.1k indexed · h-index 14
Topics
Cancer Treatment and Pharmacology (5 papers)HER2/EGFR in Cancer Research (3 papers)Advanced Breast Cancer Therapies (3 papers)

In The Last Decade

Elena Miranda

29 papers receiving 1.1k citations

Peers

Elena Miranda
Comparison fields: 5 of 94
  • Oncology 381
  • Immunology 364
  • Molecular Biology 318
  • Pulmonary and Respiratory Medicine 154
  • Cancer Research 144
Replace Susan K. Anderson with:
Susan K. Anderson United States
Rifat Hasina United States
Fei Yao China
Francesc Martí United States
Flavio Arienti Italy
Andrew J. McKenzie United States
Nicole C. Schmitt United States
F. Lejeune Switzerland
Minghua Zhu United States
Elena Miranda relative to Susan K. Anderson United States Susan K. Anderson's profile →
Citations per field
00.5×3.4×
Susan K. Anderson · 1×
Citations per year

Countries citing papers authored by Elena Miranda

Since Specialization
Citations

This map shows the geographic impact of Elena Miranda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Miranda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Miranda more than expected).

Fields of papers citing papers by Elena Miranda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Miranda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Miranda. The network helps show where Elena Miranda may publish in the future.

Co-authorship network of co-authors of Elena Miranda

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Miranda. A scholar is included among the top collaborators of Elena Miranda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Miranda. Elena Miranda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 6
3 3
4 2
5 1
6 1
7 30
8 1
9 1
10 64
11 28
12 9
13 52
14 151
15 28
16 6
17 55
18 67
19 220
20 185

About Elena Miranda

Elena Miranda is a scholar working on Cancer Research, Oncology and Immunology, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), HER2/EGFR in Cancer Research (3 papers) and Advanced Breast Cancer Therapies (3 papers). The work is most often cited by research in Immunology (364 citations), Oncology (381 citations) and Cancer Research (144 citations). Elena Miranda has collaborated with scholars based in United Kingdom, Spain and United States. Frequent co-authors include Massimo Roncalli, Paolo Bianchi, Alberto Malesci, Luigi Laghi, Martino Introna, Antonio Sica, Elisa Gotti, Luca Bologna, Monica Rimoldi and Giuseppe A. Palumbo. Their work appears in journals such as Journal of the American Chemical Society, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026